Professor Zeng Zexian's team from the Center for Quantitative Biology at the Peking University Academy for Advanced Interdisciplinary Studies, in collaboration with the Peking University-Tsinghua ...

There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

According to a recent study, researchers are developing nanotechnology that can improve the treatment of one of the most ...

A bold funding initiative aims to help scientists predict a T cell’s target antigens, with implications far beyond cancer ...

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 registration-stage immune-oncology company ...

The pharma industry, Wall Street and former government officials on Monday decried the forced resignation of FDA vaccine ...

Dr. Aaron Robinson, an ear nose and throat specialist, said it can be tough to distinguish between allergies and cold or flu ...

Teddi Mellencamp battles advanced melanoma as cancer spreads, preparing her children while undergoing treatments.